3851 - 3900 of 8808 Results
Title
Year
-
OPENTitle: Falls Risk in Relation to Activity Exposure in High-Risk Older AdultsJournal Name: The Journals of Gerontology: Series APublisher: Oxford University Press (OUP)Vol: 75Issue #: 6Start Page: 1198End Page: 1205Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/gerona/glaa007Best OA location URL: https://academic.oup.com/biomedgerontology/article-pdf/75/6/1198/33283332/glaa007.pdfCitation Count: 66
-
OPENTitle: Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivoJournal Name: Stem Cells Translational MedicinePublisher: Oxford University Press (OUP)Vol: 10Issue #: 2Start Page: 278End Page: 290Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/sctm.20-0014Best OA location URL: https://stemcellsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sctm.20-0014Citation Count: 21
-
RESTRICTEDTitle: Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical PracticeJournal Name: Molecular BiologyPublisher: Pleiades Publishing LtdVol: 54Issue #: 6Start Page: 827End Page: 839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1134/s0026893320060060Citation Count: 2
-
OPENTitle: PINK1-dependent phosphorylation of Serine111 within the SF3 motif of Rab GTPases impairs effector interactions and LRRK2-mediated phosphorylation at Threonine72Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 477Issue #: 9Start Page: 1651End Page: 1668Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20190664Best OA location URL: https://portlandpress.com/biochemj/article-pdf/477/9/1651/878955/bcj-2019-0664.pdfCitation Count: 39
-
RESTRICTEDTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 888End Page: 889Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30355-0Citation Count: 0
-
OPENTitle: Huntington's disease in BangladeshJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 644End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30216-7Best OA location URL: http://www.thelancet.com/article/S1474442220302167/pdfCitation Count: 1
-
OPENTitle: Long before Huntington's disease: what matters most?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 473End Page: 475Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30156-3Best OA location URL: http://www.thelancet.com/article/S1474442220301563/pdfCitation Count: 0
-
RESTRICTEDTitle: Developing therapies for Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 10Start Page: 797End Page: 797Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3Best OA location URL: http://www.thelancet.com/article/S1474442220303203/pdfCitation Count: 5
-
RESTRICTEDTitle: Multiple sclerosis in 2019: predicting progressionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7Citation Count: 1
-
OPENTitle: A cornerstone initiative for progress in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdfCitation Count: 1
-
RESTRICTEDTitle: Movement disorders in 2019: from antibodies to lifestyle interventionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 10End Page: 12Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30438-7Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133486Citation Count: 1
-
OPENTitle: A Survey of Rare Epigenetic Variation in 23,116 Human Genomes Identifies Disease-Relevant Epivariations and CGG ExpansionsJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 107Issue #: 4Start Page: 654End Page: 669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2020.08.019Best OA location URL: http://www.cell.com/article/S0002929720302883/pdfCitation Count: 53
-
RESTRICTEDTitle: Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 135End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30396-5Citation Count: 112
-
RESTRICTEDTitle: Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 491End Page: 501Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30108-3Citation Count: 129
-
RESTRICTEDTitle: Getting ahead in the race for a cure: How nonprofits are financing biomedical R&DJournal Name: Research PolicyPublisher: Elsevier BVVol: 49Issue #: 8Start Page: 104032End Page: 104032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104032Citation Count: 4
-
OPENTitle: Transdifferentiation of Mouse Embryonic Fibroblasts into Dopaminergic Neurons Reactivates LINE-1 Repetitive ElementsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 60End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.002Best OA location URL: http://www.cell.com/article/S2213671119304163/pdfCitation Count: 23
-
OPENTitle: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 1Start Page: 35End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7671949Citation Count: 5
-
RESTRICTEDTitle: Neural activity in functional movement disorders after inpatient rehabilitationJournal Name: Psychiatry Research: NeuroimagingPublisher: Elsevier BVVol: 303Issue #:Start Page: 111125End Page: 111125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pscychresns.2020.111125Citation Count: 27
-
RESTRICTEDTitle: Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e86End Page: e86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.312Citation Count: 0
-
OPENTitle: Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization studyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-93105-yBest OA location URL: https://www.nature.com/articles/s41598-021-93105-y.pdfCitation Count: 31
-
OPENTitle: Disrupted functional connectivity in PD with probable RBD and its cognitive correlatesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-03751-5Best OA location URL: https://www.nature.com/articles/s41598-021-03751-5.pdfCitation Count: 16
-
OPENTitle: Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-91943-4Best OA location URL: https://www.nature.com/articles/s41598-021-91943-4.pdfCitation Count: 51
-
OPENTitle: Cerebellar rTMS in PSP: a Double-Blind Sham-Controlled Study Using Mobile Health TechnologyJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 20Issue #: 4Start Page: 662End Page: 666Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-021-01239-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-021-01239-6.pdfCitation Count: 14
-
OPENTitle: Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegenerationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-91367-0Best OA location URL: https://www.nature.com/articles/s41598-021-91367-0.pdfCitation Count: 12
-
OPENTitle: Temporal trajectory of biofluid markers in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-94345-8Best OA location URL: https://www.nature.com/articles/s41598-021-94345-8.pdfCitation Count: 21
-
OPENTitle: Effect of data leakage in brain MRI classification using 2D convolutional neural networksJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-01681-wBest OA location URL: https://www.nature.com/articles/s41598-021-01681-w.pdfCitation Count: 77
-
OPENTitle: Computational medication regimen for Parkinson’s disease using reinforcement learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-88619-4Best OA location URL: https://www.nature.com/articles/s41598-021-88619-4.pdfCitation Count: 23
-
OPENTitle: Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson’s disease using machine learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-84316-4Best OA location URL: https://www.nature.com/articles/s41598-021-84316-4.pdfCitation Count: 21
-
RESTRICTEDTitle: Quality of life after hospitalization predicts one-year readmission risk in a large Swiss cohort of medical in-patientsJournal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 7Start Page: 1863End Page: 1871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11136-021-02867-5Citation Count: 3
-
OPENTitle: Microdroplet-based one-step RT-PCR for ultrahigh throughput single-cell multiplex gene expression analysis and rare cell detectionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-86087-4Best OA location URL: https://www.nature.com/articles/s41598-021-86087-4.pdfCitation Count: 24
-
OPENTitle: Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stagesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-88877-2Best OA location URL: https://www.nature.com/articles/s41598-021-88877-2.pdfCitation Count: 26
-
OPENTitle: Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 307End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00246-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00246-3.pdfCitation Count: 13
-
OPENTitle: The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanismJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 3Issue #: 3Start Page: 100261End Page: 100261Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xgen.2023.100261Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S2666979X23000174-fx1_lrg.jpgCitation Count: 36
- PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage2023OPENTitle: PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial DamageJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 66Issue #: 11Start Page: 7645End Page: 7656Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00555Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00555Citation Count: 20
- Higher Health Service Costs Associated With Delayed Diagnosis of Functional Neurological Disorder2022RESTRICTEDTitle: Higher Health Service Costs Associated With Delayed Diagnosis of Functional Neurological DisorderJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 35Issue #: 1Start Page: 86End Page: 91Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.21110288Citation Count: 20
-
RESTRICTEDTitle: Multidimensional nonadditivity in one-facet g-theory designs: A profile analytic approach.Journal Name: Psychological MethodsPublisher: American Psychological Association (APA)Vol: 28Issue #: 3Start Page: 651End Page: 663Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/met0000452Citation Count: 2
-
OPENTitle: Cumulative Effect of Head Injuries on Nonmotor Outcomes in Parkinson’s DiseaseJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 35Issue #: 2Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.21100257Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10027620/pdf/nihms-1817278.pdfCitation Count: 3
-
OPENTitle: Analysis of sleep, daytime sleepiness, and autonomic function in multiple system atrophy and Parkinson disease: a prospective studyJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 19Issue #: 1Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.10268Best OA location URL: https://jcsm.aasm.org/doi/pdf/10.5664/jcsm.10268Citation Count: 5
-
OPENTitle: Guanylyl cyclase C ameliorates visceral pain: an unsuspected linkJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 133Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci166703Best OA location URL: http://www.jci.org/articles/view/166703/files/pdfCitation Count: 1
-
OPENTitle: Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathologyJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adf3775Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adf3775?download=trueCitation Count: 25
-
OPENTitle: Structural basis for ATG9A recruitment to the ULK1 complex in mitophagy initiationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adg2997Best OA location URL: https://escholarship.org/uc/item/6m22v2xwCitation Count: 55
-
OPENTitle: Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 505End Page: 512Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000837Best OA location URL: https://doi.org/10.1037/neu0000837Citation Count: 7
-
OPENTitle: Functional characterization of the biogenic amine transporters on human macrophagesJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 7Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.151892Best OA location URL: http://insight.jci.org/articles/view/151892/files/pdfCitation Count: 24
-
OPENTitle: Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 513End Page: 519Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000809Best OA location URL: https://doi.org/10.1037/neu0000809Citation Count: 5
-
OPENTitle: Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma BiomarkersJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 11Start Page: 1155End Page: 1155Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.3265Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9552044Citation Count: 30
-
RESTRICTEDTitle: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock BenefitsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 12Start Page: 1219End Page: 1219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649Citation Count: 5
-
RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 4
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601Citation Count: 0
-
OPENTitle: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 7Start Page: e2223821End Page: e2223821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794635/wang_2022_oi_220672_1659467066.66779.pdfCitation Count: 11